Literature DB >> 29344586

Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.

Russell G Witt1,2, Emily M Kreger1,2, Laura B Buckman3, Patriss W Moradi1, Phong T Ho3, S Christopher Derderian1,2, Perry Tsai3, Chris Baker1,2, Nathaniel Schramm3, Rachel Cleary3, J Victor Garcia3, Tippi C MacKenzie1,2.   

Abstract

IUHCT of human cord blood-derived CD34+ cells into fetal NSG mice results in systemic multilineage engraftment with human cells.Preconditioning with in utero injection of an anti-c-Kit receptor antibody (ACK2) results in an improved rate of engraftment.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29344586      PMCID： PMC5761626          DOI： 10.1182/bloodadvances.2017011585

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  31 in total

1.  Hemopoietic chimerism in rodents transplanted in utero with fetal human hemopoietic cells.

Authors:  M G Pallavicini; A W Flake; D Madden; C Bethel; B Duncan; M L Gonzalgo; S Haendel; T Montoya; L Roberts
Journal:  Transplant Proc       Date:  1992-04       Impact factor: 1.066

Review 2.  In utero hematopoietic cell transplantation for the treatment of congenital anomalies.

Authors:  Amar Nijagal; Alan W Flake; Tippi C MacKenzie
Journal:  Clin Perinatol       Date:  2012-05-08       Impact factor: 3.430

Review 3.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

4.  Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.

Authors:  Jesse D Vrecenak; Erik G Pearson; Matthew T Santore; Carlyn A Todorow; Haiying Li; Antoneta Radu; Tricia Bhatti; William H Peranteau; Mark P Johnson; Alan W Flake
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

5.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

6.  In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in Swine.

Authors:  Patricia W Lee; Robert A Cina; Mark A Randolph; Ron Arellano; Jennifer Goodrich; Haley Rowland; Christene A Huang; David H Sachs; Heung Bae Kim
Journal:  Transplantation       Date:  2005-05-15       Impact factor: 4.939

7.  Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.

Authors:  A W Flake; M G Roncarolo; J M Puck; G Almeida-Porada; M I Evans; M P Johnson; E M Abella; D D Harrison; E D Zanjani
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

8.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

9.  Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.

Authors:  William H Peranteau; Todd E Heaton; Yu-Chen Gu; Susan W Volk; Thomas R Bauer; Keith Alcorn; Laura M Tuschong; Mark P Johnson; Dennis D Hickstein; Alan W Flake
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

10.  IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice.

Authors:  P W Denton; T Nochi; A Lim; J F Krisko; F Martinez-Torres; S K Choudhary; A Wahl; R Olesen; W Zou; J P Di Santo; D M Margolis; J V Garcia
Journal:  Mucosal Immunol       Date:  2012-05-09       Impact factor: 7.313
View more
  4 in total

1.  Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency.

Authors:  Alessandra Magnani; Jean-Marie Jouannic; Jérémie Rosain; Aurélie Gabrion; Fabien Touzot; Cécile Roudaut; Sven Kracker; Nizar Mahlaoui; Antoine Toubert; Emmanuel Clave; Elisabeth A Macintyre; Isabelle Radford-Weiss; Marion Alcantara; Elisa Magrin; Brigitte Ternaux; Jennifer Nisoy; Laure Caccavelli; Anne-Marie Darras; Capucine Picard; Stéphane Blanche; Marina Cavazzana
Journal:  Blood Adv       Date:  2019-02-12

Review 2.  Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.

Authors:  Chunyu Shi; Lu Pan; Zheng Hu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

Review 3.  Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia.

Authors:  Andrew J King; Douglas R Higgs
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.

Authors:  Niraja M Dighe; Kang Wei Tan; Lay Geok Tan; Steven S W Shaw; Suzanne M K Buckley; Dedy Sandikin; Nuryanti Johana; Yi-Wan Tan; Arijit Biswas; Mahesh Choolani; Simon N Waddington; Michael N Antoniou; Jerry K Y Chan; Citra N Z Mattar
Journal:  Exp Hematol       Date:  2018-03-29       Impact factor: 3.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.